Adenoviral vectors are among the oldest and most widely used vectors for gene therapy applications. Compared to other types of vectors, they have many advantages, including the extensive packaging capacity, the ability to transduce a variety of different cell types, and its potential for high-titer preparations. This report focuses on the main steps for production of first-generation adenovirus vectors as well as the introduction and principles of the most important methods to analyze and characterize adenovirus vector preparations.
Table of Contents
1. Adenovirus: structure and biology
Viral proteins
Replication of adenovirus genome
2. Types of adenoviral vectors
3. Production of adenoviral vectors
3.1 Generation of infectious plasmids
Bacterial transformation
Midiprep
Control gel-Digestion:
3.2 Transfection into producer cell lines
3.3 PEI tranfection of linearized plasmid
3.4 Harvesting of Adenovirus
3.5 Amplification of Ad vectors
3.6 Virus prep
4. Analysis and characterization
4.1 Vector titration
OD260-measurement
Slot-Blot assay
4.2 Infection with different MOI
5. Comparison of the efficiency of different vector systems
5.1 PEI Transfection
Transfection with different N/P ratios
5.2 Transfection vs. transduction efficiency
5.3 Neutralization assay
Research Objectives and Key Themes
This practical training report documents the generation, production, and analytical characterization of recombinant adenoviral vectors, while simultaneously comparing their delivery efficiency and immune evasion capabilities against synthetic polyethylenimine (PEI) transfection systems.
- Methodology for the rescue and amplification of first-generation adenoviral vectors.
- Analytical techniques for vector titration including OD260 and Slot-Blot assays.
- Comparative analysis of transduction efficiency in mammalian cell lines.
- Evaluation of optimal transfection parameters such as N/P ratios for synthetic vectors.
- Investigation of human plasma for the presence of neutralizing anti-adenoviral antibodies.
Excerpt from the Book
3.3 PEI tranfection of linearized plasmid
To start the virus production, N52 cells are Polyethylenimine (PEI) transfected in a small scale with an infectious plasmid. It is essential that this plasmid is linearized, since the Adv needs free ITR to replicate. Therefore, the plasmid pGS109#29 was digested with SwaI prior to transfection. Transfection of a 6cm dish of N52 cells was done with 1, 2 or 4 µg linearized plasmid DNA using a 7.5mM PEI at N/P 30.
3.4 Harvesting of Adenovirus
Morphological changes in cells caused by viral infection are called cytopathic effects (CPE). Examples are rounded and detached cells, or cells that form clusters. CPE was evaluated with a light microscope and additionally fluorescence was monitored with a fluorescence microscope. Upon significant CPE, cells were harvested and virus was released from the cells by three cycles of freezing in liquid nitrogen and thawing at 37°C. Cell debris was pelleted and supernatant containing virus was transferred to a new tube and stored at -80°C until required.
3.5 Amplification of Ad vectors
For further amplification, a 15cm dish of N52 cells was infected with parts of the raw lysate obtained from the first infection with 1 and 4 µg DNA. After 48 hours, the virus was again harvested as described above. At this point we observed that the supernatant from the second infection with 4 µg DNA was greener than the one from 1 µg, indicating that further amplification is needed for 1 µg DNA but not for 4 µg DNA, whose lysate could infect directly ten 15cm dishes (final infection).
Summary of Chapters
1. Adenovirus: structure and biology: This chapter covers the fundamental structural biology of adenoviruses, their protein components, and the mechanisms of viral genome replication.
2. Types of adenoviral vectors: This section provides an overview of different vector generations, ranging from first-generation to high-capacity "gutless" vectors, focusing on their respective packaging capacities and safety profiles.
3. Production of adenoviral vectors: This chapter outlines the practical workflow for generating infectious plasmids, transforming bacteria, and the subsequent processes of transfection, harvesting, and purification of viral particles.
4. Analysis and characterization: This part details the methods used to determine total and infectious particle titers and explores the determination of optimal multiplicity of infection (MOI) for transduction.
5. Comparison of the efficiency of different vector systems: This final chapter compares viral vector transduction with synthetic PEI-mediated transfection and assesses the impact of human anti-adenoviral antibodies on vector efficacy.
Keywords
Adenovirus, Gene Therapy, PEI Transfection, Vector Production, Transduction Efficiency, Slot-Blot, Cytopathic Effect, N/P Ratio, Neutralization Assay, Antibodies, Molecular Medicine, Plasmid DNA, Viral Capsid, Gene Delivery, Immunogenicity
Frequently Asked Questions
What is the primary focus of this work?
The report focuses on the experimental procedures for producing recombinant adenoviral vectors and evaluating their performance, as well as comparing them to synthetic transfection methods for gene delivery.
What are the central research themes?
The work covers viral vector engineering, titer optimization, analytical quantification of vector particles, and the impact of the human immune response on gene therapy efficacy.
What is the primary goal of the study?
The goal is to demonstrate the practical steps required for adenoviral vector rescue and to compare the effectiveness of viral delivery systems against non-viral, polymer-based (PEI) methods.
Which scientific methods are primarily employed?
The study utilizes molecular cloning, bacterial transformation, cell culture techniques, SDS-PAGE, ultracentrifugation, Slot-Blot assays, and FACS analysis for quantification.
What topics are discussed in the main section?
The main sections cover the biology of adenovirus, the step-by-step production of vectors, titration methods, MOI optimization, N/P ratio determination for synthetic vectors, and neutralization assays.
Which keywords best characterize the research?
Key terms include adenovirus, gene therapy, transduction efficiency, PEI transfection, and vector characterization.
How does the PEI transfection efficiency compare to adenoviral vectors?
The study concludes that PEI transfection is significantly less effective than adenoviral vector systems, requiring a much higher number of genomes to induce the same level of transgene expression.
What did the neutralization assay reveal about human plasma?
The assay revealed that human plasma contains both neutralizing and non-neutralizing antibodies against adenovirus, which complicates efficient gene transfer by potentially facilitating phagocytosis or directly preventing cell entry.
Why is the N/P ratio significant in PEI transfection?
The N/P ratio (nitrogen-to-phosphate ratio) is crucial as it determines the charge ratio of the DNA-PEI complex, which directly influences the efficiency of internalization and the subsequent endosomal release of the genetic material.
What is the importance of the Slot-Blot assay?
The Slot-Blot assay is essential for calculating the ratio of infectious to total virus particles, which provides a more accurate assessment of the vector's actual utility for in vivo applications compared to simple particle counts.
- Quote paper
- Simon Schwörer (Author), 2012, Adenovirus vector rescue, production and analysis, Munich, GRIN Verlag, https://www.hausarbeiten.de/document/193918
